" class="no-js "lang="en-US"> Immunology Archives - Page 5 of 11 - Medtech Alert
Friday, October 03, 2025

Sort by:

Date

Top Post

Taiwan Firm AHEAD Medicine Disrupting Cell Analysis With AI to Help Accelerate Disease Diagnostics and Cell Therapy Worldwide

AHEAD Medicine, a UC Berkeley SkyDeck-backed company has launched a new AI-enabled cell immuno-profiling analysis […]

Mymee Acquires Breakthrough Health, Leading Digital Health Platform for Multiple Sclerosis

Mymee, a leading provider of specialized care and support for people with significant symptoms associated […]

Valo Therapeutics Acquires PeptiCHIP Technology Enabling Rapid Identification of Tumor Antigens for the Development of Personalized Immunotherapies

Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapy platforms for cancer and infectious […]

Cancer Research UK and Sosei Heptares Sign Agreement to Advance Cancer Immunotherapy Candidate Into Clinical Trials

Sosei Group Corporation (“the Company”; TSE: 4565), an international biopharmaceutical company and world-leader in GPCR1-focused […]

Roche Launches Innovative Dual Antigen and Antibody Diagnostic Test Supporting the Fight to Eliminate the Hepatitis C Virus

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys® HCV Duo […]

Glaucoma Research Foundation Launches Catalyst for a Cure Initiative to Prevent and Cure Neurodegeneration

Glaucoma Research Foundation (GRF), a national non-profit organization dedicated to finding a cure for glaucoma, has […]

Adipopharma’s First-in-class Candidate - PATAS - Shows Improvement in Whole-body Insulin Resistance and Associated Comorbidities in Vivo

AdipoPharma, formerly ALMS Therapeutics SAS, a biopharmaceutical company focused on innovative peptide-based approaches to treating […]

Moderna Announces First Participant Dosed in a Phase 1 Trial of Its Nipah Virus mRNA Vaccine, mRNA-1215

Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more